Join host Dr. Chadi Nabhan and special guest Dr. Rachna Schroff, Chief, Division of Hematology/Oncology and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona as they take a deep dive into the latest highlights from this year’s ASCO-GI meeting. Explore novel oncology research, groundbreaking trials, and the transformative role molecular profiling and liquid biopsies are playing in revitalizing the field of gastrointestinal cancer. Don’t miss these essential highlights from this year’s meeting.
For more information, please visit: www.CarisLifeSciences.com
All content for Caris Molecular Minute Podcast Series is the property of Dr. Chadi Nabhan and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join host Dr. Chadi Nabhan and special guest Dr. Rachna Schroff, Chief, Division of Hematology/Oncology and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona as they take a deep dive into the latest highlights from this year’s ASCO-GI meeting. Explore novel oncology research, groundbreaking trials, and the transformative role molecular profiling and liquid biopsies are playing in revitalizing the field of gastrointestinal cancer. Don’t miss these essential highlights from this year’s meeting.
For more information, please visit: www.CarisLifeSciences.com
Interview with Dr. Stephen Liu: An In-depth Look at the ADAURA Trial
Caris Molecular Minute Podcast Series
32 minutes 19 seconds
2 years ago
Interview with Dr. Stephen Liu: An In-depth Look at the ADAURA Trial
Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephen Liu, Associate Professor of Medicine at Georgetown University and Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. Together they discuss the updated results of the ADAURA Trial presented at this year's ASCO meeting which demonstrated the overall survival benefit when adding osimertinib versus placebo in patients with completely resected stage IB-IIIA NSCLC, with/without adjuvant chemotherapy.
For more information, please visit: www.CarisLifeSciences.com
Caris Molecular Minute Podcast Series
Join host Dr. Chadi Nabhan and special guest Dr. Rachna Schroff, Chief, Division of Hematology/Oncology and co-leader of the Gastrointestinal Clinical Research Team at the University of Arizona as they take a deep dive into the latest highlights from this year’s ASCO-GI meeting. Explore novel oncology research, groundbreaking trials, and the transformative role molecular profiling and liquid biopsies are playing in revitalizing the field of gastrointestinal cancer. Don’t miss these essential highlights from this year’s meeting.
For more information, please visit: www.CarisLifeSciences.com
